The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

被引：0
|
作者：
Schwartz, Jason R. [1 ]
Walsh, Michael P. [2 ]
Ma, Jing [2 ]
Lamprecht, Tamara [2 ]
Ribeiro, Raul C. [3 ]
Klco, Jeffery M. [4 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118995
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2775
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TP53 and therapy-related myeloid neoplasms
    Chung, Jae
    Sallman, David A.
    Padron, Eric
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (01) : 98 - 103
  • [42] Therapy-related myeloid neoplasms following treatment with radioiodine
    Schroeder, T.
    Kuendgen, A.
    Strupp, C.
    Haas, R.
    Germing, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 246 - 246
  • [43] Therapy-related myeloid neoplasms: what's in a name?
    Klimek, Virginia M.
    Tray, Nancy J.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (02) : 161 - 166
  • [44] The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
    Deepak Singhal
    Li Yan A. Wee
    Monika M. Kutyna
    Rakchha Chhetri
    Joel Geoghegan
    Andreas W. Schreiber
    Jinghua Feng
    Paul P.-S. Wang
    Milena Babic
    Wendy T. Parker
    Smita Hiwase
    Suzanne Edwards
    Sarah Moore
    Susan Branford
    Teodora Kuzmanovic
    Nimit Singhal
    Raghu Gowda
    Anna L. Brown
    Peer Arts
    Luen B. To
    Peter G. Bardy
    Ian D. Lewis
    Richard J. D’Andrea
    Jaroslaw P. Maciejewski
    Hamish S. Scott
    Christopher N. Hahn
    Devendra K. Hiwase
    Leukemia, 2019, 33 : 2842 - 2853
  • [45] The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
    Singhal, Deepak
    Wee, Li Yan A.
    Kutyna, Monika M.
    Chhetri, Rakchha
    Geoghegan, Joel
    Schreiber, Andreas W.
    Feng, Jinghua
    Wang, Paul P. -S.
    Babic, Milena
    Parker, Wendy T.
    Hiwase, Smita
    Edwards, Suzanne
    Moore, Sarah
    Branford, Susan
    Kuzmanovic, Teodora
    Singhal, Nimit
    Gowda, Raghu
    Brown, Anna L.
    Arts, Peer
    To, Luen B.
    Bardy, Peter G.
    Lewis, Ian D.
    D'Andrea, Richard J.
    Maciejewski, Jaroslaw P.
    Scott, Hamish S.
    Hahn, Christopher N.
    Hiwase, Devendra K.
    LEUKEMIA, 2019, 33 (12) : 2842 - 2853
  • [46] Shorter Latencies in The Pediatric Therapy-Related Myeloid Neoplasms Highlight Their Differences from The Adult Counterparts
    Liu, Yen-Chun
    Geyer, Julia
    Rea, Bryan
    Klco, Jeffery
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 982 - 982
  • [47] Outcome of Therapy-Related Myeloid Neoplasms with Venetoclax-Based Therapy
    Shah, Mithun V.
    Chhetri, Rakchha
    Dholakia, Ruchita
    Alkhateeb, Hassan B.
    Al-Kali, Aref
    Patnaik, Mrinal M.
    Gangat, Naseema
    Wei, Andrew H.
    Tiong, Ing Soo
    Begna, Kebede H.
    Hiwase, Devendra
    BLOOD, 2021, 138
  • [48] Next generation sequencing in therapy-related myeloid neoplasms compared to de novo myeloid neoplasms
    Claerhout, Helena
    Vranckx, Hilde
    Lierman, Els
    Michaux, Lucienne
    Boeckx, Nancy
    ACTA CLINICA BELGICA, 2022, 77 (03) : 658 - 663
  • [49] Shorter Latencies in The Pediatric Therapy-Related Myeloid Neoplasms Highlight Their Differences from The Adult Counterparts
    Liu, Yen-Chun
    Geyer, Julia
    Rea, Bryan
    Klco, Jeffery
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 982 - 982
  • [50] Predicting therapy-related myeloid neoplasms-and preventing them?
    Steensma, David P.
    LANCET ONCOLOGY, 2017, 18 (01): : 11 - 13
12345